Inhaled Corticosteroids (ICS) are commonly prescribed to patients with severe COPD and
recurrent exacerbations. It is not known what impact ICS cause in terms of COVID-19 …

Inhaled corticosteroids (ICS) could increase both the risk of coronavirus disease 2019
(COVID-19) and experiencing poor outcomes. To compare the clinical outcomes between …

The coronavirus disease 2019 (COVID-19) pandemic is a worldwide tragedy. Inhaled
corticosteroids (ICS) are often used to manage asthma or chronic obstructive pulmonary …

The current coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome-coronavirus 2 (SARS-CoV-2) infection, raises important questions as to whether …

Background The effect of inhaled corticosteroids (ICS) on the clinical outcomes of patients
with coronavirus disease 2019 (COVID-19) was not known. Research design and methods …

Inhaled corticosteroids (ICSs) are widely used in patients with asthma and chronic
obstructive pulmonary disease (COPD). Herein, we are highly concerned about whether the …

The 2019 coronavirus disease (COVID-19) pandemic is caused by severe acute respiratory
syndrome-coronavirus-2 (SARS-CoV-2). Clinical outcomes, including mortality, are worse in …

Background Recent evidence has established a beneficial effect of systemic corticosteroids
for treatment of moderate‐to‐severe COVID‐19. Objective To determine if inhaled …

Background The effects of chronic inhaled and systemic corticosteroids use on COVID-19
susceptibility and severity are unclear. Since many patients with chronic pulmonary …

Objectives Use of corticosteroids is common in the treatment of coronavirus disease 2019,
but clinical effectiveness is controversial. We aimed to investigate the association of …